🇺🇸 FDA
Patent

US 7786091

Compositions and methods for ameliorating myosin VIIa defects

granted A61KA61K48/005A61P

Quick answer

US patent 7786091 (Compositions and methods for ameliorating myosin VIIa defects) held by The Regents of the University of California expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/005, A61P, A61P21/00, A61P27/02